Estela Rodriguez: Great session on ADCs for lung cancer at WCLC24

Estela Rodriguez recently tweeted:

“Saving the best for last! Great session on ADCs for lung cancer starting now at the International Association for the Study of Lung Cancer WCLC24 with co-chairs Ana Velázquez Mañana and Ignatius Ou.

Benjamin Levy starts with what makes these agents different, what are the best targets, why have we seen disappointing trial results compared to docetaxel.”

Source: Estela Rodriguez/X

Estela Rodriguez is Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. She is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and increasing access to clinical trials. Dr. Rodriguez is known to help empower women to take charge of their own healthcare and believes in the power of mentorship.